MAIA gets an FDA approval on cancer drug

The company also went public last week, raising nearly $10 million in its initial public offering as it hopes to revolutionize cancer treatment.

Source: bizjournals.com Health Care:Physician Practices headlines - August 2, 2022 Category: American Health Authors: Alex Zorn Source Type: news